Resources
Centre for Effective Practice: Opioid Tapering
https://cep.health/clinical-products/opioid-tapering-template/
Deprescribing.org: Benzodiazepine Receptor Agonist
https://deprescribing.org
Canadian Agency for Drugs and Technologies in Health
Choosing Wisely Canada
https://choosingwiselycanada.org/
The 2017 Canadian Guideline for Opioids for Chronic Non-Cancer Pain
http://nationalpaincentre.mcmaster.ca/documents/Opioid%20GL%20for%20CMAJ_01may2017.pdf
Law Enforcement Form: Notification of Charges or Suspicious Behaviour Related to Monitored Drugs
Download FileThis form has been created for use by law enforcement personnel so that they may inform the NSPMP of individuals who have been charged or are suspected of suspicious behaviour related to monitored drugs. Please note that at this time the NSPMP does not monitor benzodiazepines.
The Working with Law Enforcement Policy & Guidelines is available for download at http://www.nspmp.ca/library/00000328-library.pdf
Law Enforcement Form: Request for Monitored Prescription History
Download FileThe Request for Monitored Prescription History Form has been created for use by law enforcement personnel. The NSPMP is authorized to release patient profile information to law enforcement upon written request as long as the release of such information is in keeping with the NSPMP mandate.
A copy of the Working with Law Enforcement Policy & Guidelines is available for download at http://www.nspmp.ca/library/00000328-library.pdf
NSPMP Duplicate Prescription Pad Changes May 2018
Download FileBeginning in May 2018, prescribers will receive an updated version of the NSPMP duplicate prescription pad.
IMPORTANT: The “Signature” and “Prescribed/Written Date” fields are required elements for all NSPMP prescriptions and must be completed prior to the pharmacy visit.
Drugs Requiring the Use of a Duplicate Prescription
Download FileThe Program monitors any drug that is a controlled drug under the Controlled Drugs and Substances Act (Canada) and is listed in the Schedules of that Act except testosterone when compounded for topical application for local effect to the vaginal area and benzodiazepines. *Please note that the Drugs Requiring the Use of a Duplicate Prescription list may not be all inclusive. Some drug names may not be listed if there are no currently marketed products available or if the product is new to the market.
eAccess User Guide
Download FileEffective April 1, 2012, the Prescription Monitoring Program introduced eAccess, a new secure web application that allows prescribers and pharmacists to access patient profiles regardless of time of day. Helpful information pertaining to the eAccess web application can be found in the eAccess User Guide.
